Loading...
Loading...
Holder clone rankings through .
Of the 15 tracked institutions holding NAMS, 6 have a 3-year clone track record — 5 of them beat the S&P. Average holder's clone alpha: +10.7pt. It's a gauge of who owns the name, not just how many.
Among the 15 tracked institutional investors we monitor, NAMS (NEWAMSTERDAM PHARMA COMPANY) is held with a combined value of $834.14M across 34,222,025 shares. The largest holder is FMR LLC with a position worth $294.68M (0.01% of their portfolio). 8 funds increased their holdings. 5 funds reduced their position.
Total Institutional Value
$834.14M
Total Shares Held
34,222,025
Institutional Holders
15
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | FMR LLC | $294.68M | 0.01% | +17.2% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | $232.26M | 2.33% | - |
| 3 | Duquesne Family Office LLC | $81.65M | 1.97% | +9.3% |
| 4 | VIKING GLOBAL INVESTORS LP | $59.92M | 0.18% | -41.4% |
| 5 | MAVERICK CAPITAL LTD | $45.13M | 0.36% | -43.2% |
| 6 | PRICE T ROWE ASSOCIATES INC /MD/ | $28.54M | 0.00% | +0.5% |
| 7 | BlackRock, Inc. | $25.31M | 0.00% | -2.2% |
| 8 | MILLENNIUM MANAGEMENT LLC | $19.07M | 0.01% | +56.3% |
| 9 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $17.02M | 0.02% | +27.3% |
| 10 | Slate Path Capital LP | $7.76M | 0.12% | - |
As of the latest SEC 13F filings, FMR LLC is the largest institutional holder of NAMS with a position worth $294.68M, representing 0.01% of their portfolio. In total, 15 institutional investors hold NAMS with a combined value of $834.14M.
Institutional investors hold $834.14M worth of NAMS stock across 15 positions. The largest institutional holder is FMR LLC with $294.68M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For NAMS, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
One weekly email with notable insider buys, sells and congressional disclosures. Unsubscribe anytime.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
Last Close
$19.74
2026-11-18
YTD
-43.9%
4% of 52-week range